HighQC™ Human Bone Marrow Derived Mesenchymal Stem Cell/ Muscular Dystrophy Patient

Description

HighQC™ Human Bone Marrow Derived Mesenchymal Stem Cells (BM-MSCs) / Muscular Dystrophy (MD) Patient are primary mesenchymal stem cells isolated from bone marrow aspirates of donors with Duchenne Muscular Dystrophy (DMD). They express the specific markers of mesenchymal lineage, including CD73, CD90, and CD105, confirming their lineage identity. MD patient-derived BM-MSCs often exhibit morphological alterations and cellular dysfunction, such as impaired proliferation, differentiation defects, and increased senescence, which reflect disease-associated dysfunction. These cells provide a valuable model to investigate the molecular pathology of muscular dystrophies. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.